Nightingale Health Oyj OMXHEX:HEALTH:
STRATEGIC PARTNERSHIP WITH ALAMAR BIOSCIENCES TO INTEGRATE CUTTING-EDGE BRAIN HEALTH PROTEOMICS INTO MULTIOMICS PORTFOLIO
Nightingale Health: Strategic Partnership With Alamar Biosciences
Earlier from Nightingale Health
- Nightingale Health Oyj: Quarterly Trading Report 2025 Q3
- HEALTH: Revenue up 8% to €4.7M, strong liquidity, and major public sector and research wins
- HEALTH: 35% revenue growth, strong liquidity, and global expansion with new labs and partnerships
- HEALTH: Revenue up 4% YoY, global healthcare adoption, and strong cash position support growth targets
Later from Nightingale Health
- Terveystalo And Nightingale Health Deepen Strategic Partnership
- CFO Tuukka Paavola Leaves Nightingale Health
- North Karelia Wellbeing Services County adopts Nightingale Health’s disease risk assessment as part of public healthcare in Finland
- Inside information: Nightingale Health achieves major milestone in the United States: New York laboratory now holds a clinical laboratory permit from New York State
- HEALTH: Strong H2 revenue growth expected, driven by robust pipeline and expanded global partnerships
Follow Nightingale Health into a list and get an email when it puts out news.
Follow Nightingale Health